Horst Olschewski, MD

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Drug- or toxin-induced pulmonary arterial hypertension→
• Idiopathic pulmonary arterial hypertension→
• Idiopathic/heritable pulmonary arterial hypertension→
• Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent→
• Diffuse cutaneous systemic sclerosis→
• Chronic myeloid leukemia→
• Hypersensitivity pneumonitis→

Clinical trials (12)

• NCT00609349
• NCT03030807
• NCT02790450
• NCT00909467
• NCT01805843
• NCT00909337
• NCT01468792
• NCT01607489
• NCT03876509
• NCT01607515
• NCT04329312
• NCT02752269

Verify independently

• ClinicalTrials.gov PI search for Horst Olschewski, MD

Other specialists for Drug- or toxin-induced pulmonary arterial hypertension

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Andjela Kusic-Pajic, MD
  Actelion
• Eric Austin, MD
  Vanderbilt Medical Center
• Ekkehard Grünig, MD
  Thoraxclinic at the University of Heidelberg
• Nicholas S Hill, MD
  Tufts Medical Center
• Sudarshan Rajagopal, MD, PhD, M.D
  Duke Health System
  NC
• Richard Aranda
  Gossamer Bio Inc.
• Swee Lay Thein, M.D., MD
  National Heart, Lung, and Blood Institute (NHLBI)
  MD
• Mamta Fuloria, MD, MD
  Montefiore Medical Center
  NJ

See all specialists for Drug- or toxin-induced pulmonary arterial hypertension →